Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours Β· Estimated delivery Sep 27 - Oct 2
doi: 10.1080/08916934.2025.2576881 193 WuKZhuEChenJKuangQLinJZhaoSet al
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
One of these changes is a slower heartbeat, which means your heart beats fewer than 60 times in a minute
Rather than being excluded, patients under DAA treatment were deliberately monitored longitudinally throughout their HCV treatment up to the SVR check
US$ 23.76
US$ 21.55
US$ 29.65
US$ 29.05
